|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ELN 6-K filed Mar 30, 2009. Alzheimers
Drug Discovery Foundation (ADDF)
ADDF, a biomedical venture philanthropy, is the only public
charity solely dedicated to rapidly accelerating the discovery
and development of drugs to prevent, treat and cure
Alzheimers disease and cognitive aging. On 16 April
2008, ADDF and Elan announced the winners of their third annual
research award programme, Novel Approaches to Drug Discovery for
Alzheimers Disease. Four international scientists received
a total of $530,000 in grant funding.
This excerpt taken from the ELN 20-F filed Feb 26, 2009. Alzheimers
Drug Discovery Foundation (ADDF)
ADDF, a biomedical venture philanthropy, is the only public
charity solely dedicated to rapidly accelerating the discovery
and development of drugs to prevent, treat and cure
Alzheimers disease and cognitive aging. On April 16,
ADDF and Elan announced the winners of their third annual
research award program, Novel Approaches to Drug Discovery for
Alzheimers Disease. Four international scientists received
a total of $530,000 in grant funding.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for ELN: |
| |||||||